Response to: 'Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients' by Buch et al. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/annrheumdis-2019-215903
PubMed Identifier: 31302598
Publication URI: http://europepmc.org/abstract/MED/31302598
Type: Journal Article/Review
Volume: 79
Parent Publication: Annals of the rheumatic diseases
Issue: 11
ISSN: 0003-4967